Cargando…
Understanding the lingering consequences of what we treat and what we do
Granja and colleagues have helped us by showing that long-term follow-up is feasible and by trying to tease out whether select intensive care unit patient populations are at particular risk of adverse outcomes. This work gives us clues for future investigations which will hopefully interrogate furth...
Autor principal: | Angus, Derek C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420046/ https://www.ncbi.nlm.nih.gov/pubmed/15025769 http://dx.doi.org/10.1186/cc2838 |
Ejemplares similares
-
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
por: Agarwal, Rajiv, et al.
Publicado: (2011) -
Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009) -
Breast cancer risk perception: what do we know and understand?
por: Hopwood, Penelope
Publicado: (2000) -
Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010) -
Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)